ArticleLancet (London, England)2020
Use of adenovirus type-5 vectored vaccines: a cautionary tale.
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Vaccines for COVID-19: learning from ten phase II trials to inform clinical and public health vaccination programmes.Public health · 2021Pooled it
- Trial
- Dynamics of HIV reservoirs following repeated anti-SARS-CoV-2 vaccination.Frontiers in immunology · 2026Review
- Developing the next-generation of adenoviral vector vaccines.Human vaccines & immunotherapeutics · 2025Review
- Progress and Recent Developments in HIV Vaccine Research.Vaccines · 2025Review
- COVID-19 vaccines: history of the pandemic's great scientific success and flawed policy implementation.Monash bioethics review · 2024Article
- Public Discourse, User Reactions, and Conspiracy Theories on the X Platform About HIV Vaccines: Data Mining and Content Analysis.Journal of medical Internet research · 2024Article
- Vaccine Strategies to Elicit Mucosal Immunity.Vaccines · 2024Review
- Article
- Advances in Research on COVID-19 Vaccination for People Living with HIV.Infectious diseases & immunity · 2022Article
- Current clinical status of new COVID-19 vaccines and immunotherapy.Environmental science and pollution research international · 2022Review
- Adenovirus-based vaccines-a platform for pandemic preparedness against emerging viral pathogens.Molecular therapy : the journal of the American Society of Gene Therapy · 2022Review
- National strategies for vaccination against COVID-19 in people living with HIV in Central and Eastern European region.HIV medicine · 2022Article
- COVID-19 vaccination and HIV-1 acquisition - Authors' reply.Lancet (London, England) · 2022Article
- COVID-19 vaccination and HIV-1 acquisition.Lancet (London, England) · 2022Article
- Review
- Safety and Efficacy of the Common Vaccines against COVID-19.Vaccines · 2022Review
- HIV and SARS-CoV-2 Co-infection: Epidemiological, Clinical Features, and Future Implications for Clinical Care and Public Health for People Living with HIV (PLWH) and HIV Most-at-Risk Groups.Current HIV/AIDS reports · 2022Review
- Impact of Chronic HIV Infection on SARS-CoV-2 Infection, COVID-19 Disease and Vaccines.Current HIV/AIDS reports · 2022Review
- Evolution of drug delivery systems: From 1950 to 2020 and beyond.Journal of controlled release : official journal of the Controlled Release Society · 2022Article
Corrections and comments
- Commented on by
- Comment on
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.